SA
Sign upLog In

Novo Nordisk A/S Common Stock (NVO)

Cost of Revenue

kr 17.10B

Quarterly · Period ending: · DKK

NVO logo

NVO Cost of Revenue

Latest reportedkr 17.10B DKK
NVO Quarterly Cost of Revenue · DKK (kr 0.00 → kr 17.10B)
High-resolution chart · PNG

NVO cost of revenue history

Quarterly · DKK. Dates are reporting period ends; fiscal years can differ from calendar years.

Novo Nordisk A/S Common Stock Cost of Revenue — Quarterly (DKK)
Period endingCost of Revenue (DKK)
17,100,000,000
13,598,000,000
15,148,000,000
17,904,000,000
12,846,000,000
12,890,000,000
13,024,000,000
11,308,000,000
10,274,000,000
9,916,000,000
10,014,000,000
9,713,000,000
7,856,000,000
8,182,000,000
8,262,000,000
7,200,000,000
6,069,000,000
6,917,000,000
6,241,000,000
6,059,000,000
5,547,000,000
5,811,000,000
5,619,000,000
5,155,000,000
4,772,000,000
5,386,000,000
5,432,000,000
5,075,000,000
4,849,000,000
4,732,000,000
4,653,000,000
4,415,000,000
4,352,000,000
4,197,000,000
4,700,000,000
4,272,000,000
4,409,000,000
4,251,000,000
4,918,000,000
3,986,000,000
4,045,000,000
4,234,000,000
4,608,000,000
3,847,000,000
3,859,000,000
3,874,000,000
3,999,000,000
3,426,000,000
3,671,000,000
3,466,000,000
3,400,000,000
3,525,000,000
3,606,000,000
3,609,000,000
3,153,000,000
3,485,000,000
3,424,000,000
3,403,000,000
3,122,000,000
3,251,000,000
3,099,000,000
3,117,000,000
3,085,000,000
2,936,000,000
2,969,000,000
2,690,000,000
2,635,000,000
2,685,000,000
2,610,000,000
2,508,000,000
2,564,330,000
2,606,000,000
2,554,483,000
2,413,000,000
2,611,329,300
2,512,311,000
2,359,865,000
2,321,688,000
2,583,594,000
2,341,040,000
2,253,314,000
2,413,211,000
2,516,264,000
2,357,178,000
2,203,293,000
2,086,274,000
2,228,824,000
2,088,552,000
1,943,823,000
1,836,765,000
0
0
0
0
0
0
0
0
0
0
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.